Invention Application
- Patent Title: TRICYCLIC COMPOUNDS AS ANTICANCER AGENTS
- Patent Title (中): 三聚氰胺作为反应剂
-
Application No.: US15150492Application Date: 2016-05-10
-
Publication No.: US20160333013A1Publication Date: 2016-11-17
- Inventor: Derek J. Norris , Wayne Vaccaro , Mikkel V. DeBenedetto , Andrew P. Degnan , George V. Delucca , Jeffrey A. Deskus , Wen-Ching Han , Godwin Kwame Kumi , William D. Schmitz , John E. Starrett, JR. , Matthew D. Hill , Hong Huang
- Applicant: Bristol-Myers Squibb Company
- Main IPC: C07D471/14
- IPC: C07D471/14 ; A61K31/5377 ; A61K31/496 ; A61K31/444 ; A61K31/541 ; A61K31/675 ; A61K31/4545 ; C07D519/00 ; A61K31/439 ; A61K31/554 ; C07F9/6561 ; A61K31/683 ; A61K31/4375 ; A61K31/519
Abstract:
The present invention is directed to tricyclic compounds of the formula wherein all substituents are defined herein, as well as pharmaceutically acceptable compositions comprising compounds of the invention and methods of using said compositions in the treatment of various disorders.
Public/Granted literature
- US09725449B2 Tricyclic compounds as anticancer agents Public/Granted day:2017-08-08
Information query
